1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
(
- Contribution to journal › Article
- 2006
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article
-
Mark
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
(
- Contribution to journal › Article
- 2005
-
Mark
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: Long-term follow-up
(
- Contribution to journal › Article
-
Mark
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
(
- Contribution to journal › Article
- 2004
-
Mark
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
(
- Contribution to journal › Article
- 2002
-
Mark
Acute myeloid leukemia with inv(16)(p13q22): Involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign.
(
- Contribution to journal › Article
-
Mark
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group
(
- Contribution to journal › Article
- 1997
-
Mark
Poor survival in t(8;21) (q22;q22)-associated acute myeloid leukaemia with leukocytosis
(
- Contribution to journal › Article
- 1993
-
Mark
Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia
(
- Contribution to journal › Article